ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rosen, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rosen, P.
Annals of Clinical and Laboratory Science, Vol 9, Issue 2, 144-156
Copyright © 1979 by Association of Clinical Scientists


Articles

The pathological classification of human mammary carcinoma: past, present and future

PP Rosen

The current classification of mammary carcinoma combines pathological and clinical information in order to define prognostically significant categories. Basic structural features are the anatomic unit of origin, either duct or terminal duct-lobule complex, and the presence or absence of invasion. Approximately 90 percent of carcinomas appear to arise from ducts. About one-fifth of invasive duct carcinomas have a better than average prognosis and distinct light microscopic structural patterns. Future study of biochemical markers may permit further refinement of the existing classification of breast carcinoma and lead to the identification of new prognostically significant categories in the heterogeneous group currently referred to as "ordinary" infiltrating duct carcinoma. However, a conservative approach should be adopted toward altering or abandoning the existing classification of breast carcinoma on the basis of immunocytochemical studies until there is an adequate opportunity to determine which, if any, markers are truly clinically relevant.


This article has been cited by other articles:


Home page
Exp. Biol. Med.Home page
B.-H. Bay, R. Jin, J. Huang, and P.-H. Tan
Metallothionein as a prognostic biomarker in breast cancer.
Experimental Biology and Medicine, October 1, 2006; 231(9): 1516 - 1521.
[Abstract] [Full Text] [PDF]


Home page
Vet PatholHome page
C. E. Wood, A. L. Usborne, M. F. Starost, R. P. Tarara, L. R. Hill, L. M. Wilkinson, K. R. Geisinger, E. A. Feiste, and J. M. Cline
Hyperplastic and neoplastic lesions of the mammary gland in macaques.
Vet. Pathol., July 1, 2006; 43(4): 471 - 483.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. M. Gapstur, M. Morrow, and T. A. Sellers
Hormone Replacement Therapy and Risk of Breast Cancer With a Favorable Histology: Results of the Iowa Women's Health Study
JAMA, June 9, 1999; 281(22): 2091 - 2097.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by the Association of Clinical Scientists.